JPH0131904B2 - - Google Patents
Info
- Publication number
- JPH0131904B2 JPH0131904B2 JP55011953A JP1195380A JPH0131904B2 JP H0131904 B2 JPH0131904 B2 JP H0131904B2 JP 55011953 A JP55011953 A JP 55011953A JP 1195380 A JP1195380 A JP 1195380A JP H0131904 B2 JPH0131904 B2 JP H0131904B2
- Authority
- JP
- Japan
- Prior art keywords
- blood
- storage container
- blood storage
- hemolysis
- emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000004369 blood Anatomy 0.000 claims abstract description 97
- 239000008280 blood Substances 0.000 claims abstract description 97
- 230000002587 anti-hemolytic effect Effects 0.000 claims abstract description 36
- 239000000839 emulsion Substances 0.000 claims abstract description 32
- 238000003860 storage Methods 0.000 claims abstract description 23
- 206010018910 Haemolysis Diseases 0.000 claims abstract description 19
- 239000003219 hemolytic agent Substances 0.000 claims abstract description 18
- 230000008588 hemolysis Effects 0.000 claims abstract description 15
- 239000004094 surface-active agent Substances 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 39
- 229920003023 plastic Polymers 0.000 claims description 31
- 239000004033 plastic Substances 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 21
- 239000004014 plasticizer Substances 0.000 claims description 19
- -1 aliphatic ester Chemical class 0.000 claims description 13
- 239000003112 inhibitor Substances 0.000 claims description 10
- 125000001931 aliphatic group Chemical group 0.000 claims description 9
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 claims description 4
- KRADHMIOFJQKEZ-UHFFFAOYSA-N Tri-2-ethylhexyl trimellitate Chemical compound CCCCC(CC)COC(=O)C1=CC=C(C(=O)OCC(CC)CCCC)C(C(=O)OCC(CC)CCCC)=C1 KRADHMIOFJQKEZ-UHFFFAOYSA-N 0.000 claims description 4
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 claims description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 4
- HBGGXOJOCNVPFY-UHFFFAOYSA-N diisononyl phthalate Chemical group CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C HBGGXOJOCNVPFY-UHFFFAOYSA-N 0.000 claims description 4
- YEVQZPWSVWZAOB-UHFFFAOYSA-N 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC=C(I)C(CBr)=C1 YEVQZPWSVWZAOB-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- ZVFDTKUVRCTHQE-UHFFFAOYSA-N Diisodecyl phthalate Chemical group CC(C)CCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC(C)C ZVFDTKUVRCTHQE-UHFFFAOYSA-N 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 235000012000 cholesterol Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 125000004437 phosphorous atom Chemical group 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 4
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 150000007519 polyprotic acids Polymers 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 abstract description 11
- 150000002430 hydrocarbons Chemical group 0.000 abstract description 4
- 230000009467 reduction Effects 0.000 abstract description 3
- 150000002194 fatty esters Chemical class 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 10
- 229920000053 polysorbate 80 Polymers 0.000 description 10
- 102000001554 Hemoglobins Human genes 0.000 description 8
- 108010054147 Hemoglobins Proteins 0.000 description 8
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- 239000004800 polyvinyl chloride Substances 0.000 description 5
- 229920000915 polyvinyl chloride Polymers 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 3
- 229920000058 polyacrylate Polymers 0.000 description 3
- 229920000098 polyolefin Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KCXZNSGUUQJJTR-UHFFFAOYSA-N Di-n-hexyl phthalate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCC KCXZNSGUUQJJTR-UHFFFAOYSA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000012503 blood component Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012633 leachable Substances 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Chemical group CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- ROPXFXOUUANXRR-YPKPFQOOSA-N bis(2-ethylhexyl) (z)-but-2-enedioate Chemical compound CCCCC(CC)COC(=O)\C=C/C(=O)OCC(CC)CCCC ROPXFXOUUANXRR-YPKPFQOOSA-N 0.000 description 1
- SAOKZLXYCUGLFA-UHFFFAOYSA-N bis(2-ethylhexyl) adipate Chemical compound CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC SAOKZLXYCUGLFA-UHFFFAOYSA-N 0.000 description 1
- WXZOXVVKILCOPG-UHFFFAOYSA-N bis(2-ethylhexyl) benzene-1,3-dicarboxylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC(C(=O)OCC(CC)CCCC)=C1 WXZOXVVKILCOPG-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000012611 container material Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- PUFGCEQWYLJYNJ-UHFFFAOYSA-N didodecyl benzene-1,2-dicarboxylate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCCCCC PUFGCEQWYLJYNJ-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical class CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
- A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
ãã«ããã«è¡æ¶²ããã°ã¯ææã®åçš®è¡æ¶²æåã
äŸãã°ããã¯ããèµ€è¡çãè¡æŒ¿ãè¡å°æ¿ããã³å¯
æ§æ²ãã³ãåŸãããã«ç¡èæ¡ä»¶äžã§è¡æ¶²ãæ¡é
ããåŠçããããã«ãã¯ã¹ã¿ãŒããã©ãããŒã«ã
ã©ãã©ããªãŒãºãã€ã³ã³ãŒãã¬ã€ãããã®ããšã³
ãŠãªãŒã«éšéããåžè²©ãããŠããã çŸåšå ¥æãåŸãè¡æ¶²ããã¯ã¯ããšã¹ãã«ã¿ã€ã
ã®å¯å¡å€ãšããŠãžâïŒâãšãã«ããã·ã«ãã¿ã¬ãŒ
ããå«ãããªå¡©åããã«çµæç©ããã§ããŠããã
ããªå¡©åããã«èªäœã¯å®¹åšãšããŠäœ¿çšããããã«
é©åœãªå¯ææ§ãã©ã¹ããã¯ææã§ã¯ãªãã®ã§ãã
ã®ãããªå¯å¡å€ã¯ããªå¡©åããã«çµæç©ã«ã¯çµ¶å¯Ÿ
å¿ èŠã§ããããã®ãããªè¡æ¶²ããã°ã¯è¡æ¶²ããã³
è¡æ¶²æåã®è²¯èµããã³åŠçã«æ¥µããŠè¯ã圹ç«ã¡ã
äŸãã°21æ¥è²¯èµåŸã«ãããŠäœãè¡æŒ¿ãã¢ã°ããã³
å«éã®ããšã«é«ãçåçã瀺ããŠæ¥ãã è¡æ¶²ããã°ææã®åè£ãšããŠå¯ææ§ããªãšã¹ã
ã«ãããªãªã¬ãã€ã³ãªã©ãå«ãä»ã®å¡©çŽ äžå«ãã©
ã¹ããã¯çµæç©ãè©Šéšããããé©ãã¹ãããšã«ã
è©Šéšããææã®å€æ°ã¯ãè¡æ¶²ããã°ã®è£œäœã«è¯ã
ãã©ã¹ããã¯ææã§ããããšã®æ瀺ãäžãããã
ã©ããæ®éã®è¡æ¶²è²¯èµæ¡ä»¶äžã«ãã®ãããªææã§
ã€ãã€ã容åšäžã«è²¯èµããè¡æ¶²ããäŸãã°21æ¥è²¯
èµåŸå¥œãŸãããªãé«ãè¡æŒ¿ãã¢ã°ããã³å«éã瀺
ãããšãçããããèµ€è¡çã®æº¶è§£çãé«ãããšã
瀺ããã æ¬çºæã«ããã°ãé©ãã¹ãããšã«ããçš®ã®ãšã¹
ãã«ã¿ã€ãã®å¯å¡å€ã®ååšã¯ããã®ãããªãšã¹ã
ã«ã¿ã€ãã®å¯å¡å€ãå«ãŸãªãåãæ§ãªãã©ã¹ãã
ã¯ææããã€ãã€ã容åšãšæ¯èŒããŠãè¡æ¶²ãé·æ
é貯èµããéè¡æŒ¿ãã¢ã°ããã³å«éã®èããäœäž
ãçããããããšãçºèŠãããããã®ããšã¯ç°ãª
ã€ãå©çããã³ææã®æ§è³ªãæã€ããããããã
ã«ããããããåžè²©ã®ããªå¡©åããã«çµæç©ã§ä»
ã®ãšããå®çŸå¯èœãªã®ãšåæ§ã«é·æé貯èµäžå¥œãŸ
ããäœã溶è¡çã瀺ãå¡©çŽ äžå«ãã©ã¹ããã¯çµæ
ç©ã§ã€ãã€ãè¡æ¶²ããã°ããã³ãã®ä»ã®è¡æ¶²ãšæ¥
觊ããå»çå ·ãæäŸããããšã«å©çšããããšãã§
ããã æ¬çºæã«ããã°ãå°éããŠãŒãããã³ã·ãŒã«ã
ãå°éå£ãããªããã·ãŒã«ããå¯ææ§ã®éæãªå®¹
åšãããªãè¡æ¶²ããã°ãŸãã¯ãã®é¡äŒŒç©ãæäŸã
ãããè¡æ¶²ã¯ãå¯ææ§ã®è¡æ¶²ãšå ±åãåŸããæ» è
å¯èœãªå¡©çŽ äžå«ãã©ã¹ããã¯çµæç©ãããªããã
ã®äžã«åæ£ãããäŸãã°çåæ°ŽçŽ éäžã«ãããã
ïŒãªãã12åã®ççŽ ååã®èèªæçåæ°ŽçŽ åºãå«
ãå°ãªããšãäºã€ã®ãšã¹ãã«çµåãå«ãèèªæãš
ã¹ãã«ãããªããè¡æ¶²ã§æœåºãåŸãç©è³ªã奜ãŸã
ãã¯ïŒãªãã70ééïŒ ãå«ããã©ã¹ããã¯çµæç©
ãããªãããã°äžã«äœæ¥éãä¿åããããšãã§ã
ãã ãšã¹ãã«çµåïŒäŸãã°ïŒ¯ â âOCâïŒäžã® èèªæçåæ°ŽçŽ åºã¯ã奜ãŸããã¯ççŽ æ°ïŒãªãã
10ã®ã¢ã«ãã«åºã§ããããšã¹ãã«çµåã¯ã奜ãŸã
ãã¯éã®äºãã«é£æ¥ããççŽ ååãžçµåãããã
ãããããçåæ°ŽçŽ åºãé«åºŠã«äŒžçž®æ¯åæ§ãäŸã
ã°ãžâïŒâãšãã«ããã·ã«ã¢ãžããŒãäžã®é£œåçŽ
éçåæ°ŽçŽ éã®ããã§ããã°ããã€ãšé ãé¢ãã
ãšã¹ãã«åºãããè¯ãçµæãåŸãããšãã§ããã ãšã¹ãã«çµåã®èèªæçåæ°ŽçŽ åºã®äŸã¯ããªã¯
ãã«ããããã«ãããã«ããã·ã«ãŸãã¯ïŒâãšã
ã«ããã·ã«ã®ãããªå¥œãŸããã¢ã«ãã«åºã§ããã
奜ãŸããã¯ã該èèªæçåæ°ŽçŽ åºã¯åå²ããŠã
ããããã·ã«ããã³ããã·ã«ã®ãããªä»ã®åºããŸ
ã䜿çšã§ããããŸããäžé£œåçµåãäžã€ãŸãã¯äº
ã€ä»¥äžå«ããªã¯ããã«ããããã«ãŸãã¯ãã»ãã«
ã®ãããªé¡äŒŒã®ã¢ã«ã±ãã«åºã䜿çšã§ããã ãšã¹ãã«ç©è³ªã®äŸã¯ããžã€ãœããã«ãã¿ã¬ãŒã
ããã³ãžã€ãœãã·ã«ãã¿ã¬ãŒãã§ããã䜿çšãåŸ
ãä»ã®æº¶è¡é²æ¢å€ã¯ããžâïŒâãšãã«ããã·ã«ã
ã¬ãšãŒãããžããã«ãã¿ã¬ãŒãããžããã·ã«ãã¿
ã¬ãŒãããžããã·ã«ãã¿ã¬ãŒãããžâïŒâãšãã«
ããã·ã«ã¢ã¶ã¬ãŒãããžâïŒâãšãã«ããã·ã«ã€
ãœãã¿ã¬ãŒããããã³ãžâïŒâãšãã«ããã·ã«ã
ã¬ãšãŒããå«ã¿ãããããã¹ãŠã¯è¡æ¶²ãšã®åæ£æ¥
觊ã«ãããŠæº¶è¡é²æ¢å¹æãçºæ®ããããšã¹ãã«å
溶è¡é²æ¢å€ã®ãšãã«ãžãšã³ãæ·»å ããããšãã§ã
ãã äŸãã°ãè¡æ¶²ã¯ã溶è¡é²æ¢å€äŸãã°äžèšã®ã¿ã€
ãã®èèªæãšã¹ãã«ã®ãšãã«ãžãšã³ãããšãã«ãž
ãšã³ã®äžååšäžã®åæ§ã®è²¯èµæ¡ä»¶ã«ãããè¡æ¶²ãš
æ¯èŒãããšãã貯èµããè¡æ¶²äžã®æº¶è¡ã®æžå°ãç
ããããã®ã«å åãªéã«ãããŠå容ãããè¡æ¶²ãš
å ±åãåŸã容åšäžã«äœæž©ã«ãããŠïŒæ¥ä»¥äžã®æé
çäœå€ã§è²¯èµããããšãã§ããã 奜ãŸããã¯ã該ãšãã«ãžãšã³ã¯è¡æ¶²ãšå ±åãåŸ
ãçé¢æŽ»æ§å€ãã該ãšãã«ãžãšã³ãäžå®æéãå°
ãªããšãè¡æ¶²ã®è²¯èµæéã®éå®å®åããã®ã«å å
ãªéå«æãããå¿è«æ°žä¹ ã«å®å®ãªãšãã«ãžãšã³ã
奜ãŸããããã®ãããªãšãã«ãžãšã³ã¯ãäžè¬ã«æº¶
è¡é²æ¢å€ãäŸãã°åèšã®èèªæãšã¹ãã«ãšãè¡æ¶²
ãšå ±åãåŸãçé¢æŽ»æ§å€ãšããå®è³ªäžæ°Žã®äžååš
äžã«æ··åããããšã«ãã€ãŠè£œé ãåŸããç·å¯ã«æ··
ååŸãåŸãããæ··åç©ãæ°Žæåãžæ·»å ããšãã«ãž
ãšã³ã圢æãããããã®ãšãã«ãžãšã³ã¯ä»ã®ãšã
ã«ãžãšã³åæè¡ããã®çµæãšå察ã«ãæ°žä¹ ã«å®å®
ã§ããã ããã«ä»£ããŠãã©ã¹ããã¯å®¹åšææèªäœãäŸã
ã°å¯ææ§ã®è¡æ¶²ãšå ±åãåŸãæ» èå¯èœãªå¡©çŽ äžå«
ãã©ã¹ããã¯çµæç©ãã該ãã©ã¹ããã¯ããã°æ
æã®çµæã®äžéšãšããŠã溶è¡é²æ¢å€ã®å šéšãŸãã¯
äžéšãå«æããŠããŠããããäŸãã°ã該ãã©ã¹ã
ãã¯ææã¯ããã®äžãžåæ£ãã溶è¡é²æ¢å€ã®15ãª
ãã40ééïŒ ãããã©ã¹ããã¯ããã°ææãšè¡æ¶²
ãšã®é·æéã®æ¥è§Šã«ãã€ãŠæº¶è¡é²æ¢å€ã貯èµæé
äžè¡æ¶²äžãžæµžåºãããããªæ æ§ã§å«æããããšã
ã§ããã ããã«æ¬çºæã«ãããŠäœ¿çšãããèèªæãšã¹ã
ã«ã¯ã奜ãŸããã¯ççŽ ååïŒãªãã12ã®èèªæãš
ã¹ãã«çµåãåããªã³ååãžçµåããŠãããªã³é ž
ãšã¹ãã«ã§ããããäŸãã°ããªãªã¯ãã«ãã¹ããš
ãŒãã䜿çšããããšãã§ããã 䜿çšããããšãã§ããä»ã®æº¶è¡é²æ¢å€ã¯ãããª
ãšãã«ããã·ã«ããªã¡ãªããŒãã®ãããªãšãã«ãž
ãšã³ã®åœ¢ã§æŽ»æ§ã瀺ãäžå®èœæ§ãšã¹ãã«ãšããã
ãŠãã¯ããšãã«ãžãšã³ã®åœ¢ã§æŽ»æ§ã瀺ãããªãªã¯
ãã«ãã¬ãã¿ã¬ãŒãã®ãããªèèªæãšã¹ãã«åºã
ççŽ ååäžã§é£æ¥ããªãä»ã®ãšã¹ãã«ãå«ãã äžè¬ã«æº¶è¡é²æ¢å€ã¯ã溶è¡é²æ¢å€ãšè¡æ¶²ãšã®é
ã§æ¡æ£äº€æããã€ãããšè¡ãããããã«é«åºŠã«å
æ£ãã溶è¡é²æ¢å€ã貯èµè¡æ¶²ãšæ¥è§Šãããããšã«
ãã€ãŠæå¹ãšãªãåŸãããšãã«ãžãšã³ã¯ãè¡æ¶²äž
奜ãŸããã¯50ãªãã100ppmã®æ¿åºŠãäžãããã
ã«æ£ç¢ºã«å¶åŸ¡ãããéã®æº¶è¡é²æ¢å€ãæ·»å ããã
ãšãã§ããã®ã§ãããã«äœ¿çšãããšãã«ãžãšã³ã
奜ãŸããã溶è¡é²æ¢å€ãè¡æ¶²ãžæ·»å ããä»ã®å€§ãŸ
ããªæè¡ã¯ãç¹ã«è¡æ¶²è²¯èµã®æåã®æ°æ¥éã«ãã
ãŠãè¡æ¶²çžãžç§»è¡ãã溶è¡é²æ¢å€ã®äžå åãªéã
çãåŸããä»æ¹æº¶è¡é²æ¢å€ã®å€§ãŸããªéå°ã¯ãè¡
液ã容åšãžæ·»å ããåã«å®¹åšã®åŽé¢ã溶è¡é²æ¢å€
ã§ã³ãŒãã€ã³ã°ãããããªãå¶åŸ¡ãããªãæè¡ã«
ãã€ãŠè¡æ¶²äžãžç§»è¡ãããããšãã§ããã ããã«äŸãã°ãI.C.I.ã¢ã¡ãªã«ã¹ç€Ÿãã販売ã®
Tween80ã®ãããªããœã«ãã¿ã³ç¡æ°Žç©ã®æ··åéš
åãªã¬ã€ã³é žãšã¹ãã«ã®ããªãªãã·ãšãã¬ã³ãšãŒ
ãã«ã®è€åæ··åç©ã§ããããªãœã«ããŒã80ïŒç±³åœ
è¬å±æ¹ïŒã®ãããªãã©ã®ãããªè¡æ¶²ãšå ±åãåŸã
éæ¯æ§ä¹³åå€ã䜿çšããŠããããä»ã®é©åœãªä¹³å
å€ã¯ãå瀟ããTween40ã®å称ã§è²©å£²ãããŠã
ããããªãªãã·ãšãã¬ã³ïŒ20ïŒãœã«ãã¿ã³ã¢ãã
ã«ãããŒãã§ãããä»ã®äœ¿çšãåŸãä¹³åå€ã¯ã³ã¬
ã¹ãããŒã«ããã³ã¬ã·ãã³ãå«ã¿ããããã¯éåžž
äœå ã«èŠåºãããã®ã§æå©ã§ããã 䜿çšã«éããæ¬çºæã®ãšãã«ãžãšã³ã¯ãCPD
ãŸãã¯ACDã®ãããªéåžžè¡æ¶²ããã°äžã«èŠãã
ãä¿åæ é€å€ãšäžæã«æ®éã®è¡æ¶²ããã°äžãžå ã
ãããã ããã°äžã®æº¶è¡é²æ¢å€ã®æ¿åºŠããã³ååžã¯ãã
ãã°ãžè¡æ¶²ãå å¡«ããŠé·æéä¿åãããšããè¡æ¶²
äžã®æº¶è¡é²æ¢å€ã®æ¿åºŠã21æ¥éã«ããã€ãŠå žåç
ã«ã¯è¡æ¶²ïŒmlåœãçŽ30ãªãã100ÎŒgããããŠå¥œãŸ
ããã¯50ãªãã80ÎŒgãžäžæãããããªãã®ã§ã
ãããšãç¹ã«æãŸãããããã¯æº¶è¡é²æ¢å€ããã©
ã¹ããã¯ææããè¡æ¶²ãžæº¶è§£ãã圢ã§æœåºããã
ããã«ãããåŸãã ããæããªãã°ãå容ãããè¡æ¶²ãšæ¥è§Šããã
ãã°ææã®äžéšã®ã¿ãæ¬çºæã®æº¶è¡é²æ¢å€ãå«æ
ããŠããããã奜ãŸããã¯å šäœã®ããã°ææã溶
è¡é²æ¢å€ãå«æããããã®ä»£ãã«ãã©ã¹ããã¯ã®
ã·ãŒãããã©ã¹ããã¯ã®ããŒãºãã®ä»ã®ãããªã
ã©ã¹ããã¯ã€ã³ãµãŒããè¡æ¶²ããã°å ã«ååšã
ãããããŠè©²ã€ã³ãµãŒãã溶è¡é²æ¢å€ãå«æãã
å®éã®ããã°å£ã¯æ¯èŒçãã®ãããªæº¶è¡é²æ¢å€ã
å«ãŸãªãããã«ããŠãããããããäž¡æ¹ã®å Žåãš
ããäžè¬çã«å®è³ªäžããã°å šäœã®ææã«è¡æ¶²ã§æœ
åºãåŸã溶è¡é²æ¢å€ã®å¥œãŸãã䜿çšãšåçã§ã
ãã å¯å¡å€ãšããŠãäœçšãåŸãè¡æ¶²ã§æœåºãåŸã溶
è¡é²æ¢å€ã¯ã奜ãŸããã¯å¯ææ§ããã°å£äžã«ïŒãª
ãã50ééïŒ ãããã³å žåçã«ã¯çŽ15ãªãã40é
éïŒ ååšããã ãã©ã¹ããã¯ã€ã³ãµãŒãã䜿çšãããšãã¯ãã€
ã³ãµãŒãäžã®è¡æ¶²ã§æœåºãåŸã溶è¡é²æ¢å€ã®æ¿åºŠ
ã¯ãææã«ããçŽ70ïŒ ãŸã§é«ããããšãã§ããã
ããã¯ã€ã³ãµãŒãã¯éåžžæ§é æã§ã¯ãªãããããŠ
é«ãåŒåŒµã匷床ãæã€å¿ èŠããªãããã§ããã äžè¿°ã®è¡æ¶²ããã°ã®äœ¿çšã¯ã溶è¡é²æ¢å€ãå«ãŸ
ãªã察å¿ããããã°äžã«ãããŠåãæ¡ä»¶ã§è²¯èµã
ãè¡æ¶²ãšæ¯èŒãããšããæ®éã®æ¡ä»¶ã§21æ¥é貯èµ
ããè¡æ¶²ã«ãã€ãŠçæãããè¡æŒ¿ãã¢ã°ããã³ã®
å®è³ªçãªæžå°ãããããããšãã§ããã ããæããªãã°ãæ¬çºæã®çµæã¯å»ççšããŠãŒ
ãããã³ãã®ä»ã®åšå ·ã補é ããããã«äœ¿çšãã
ããšãã§ããã æ¬çºæã«äœ¿çšãããææã¯ãå Žåã«ãã€ãŠæœåº
ãåŸã溶è¡é²æ¢å€ã®ææéãå«æããããªãšã¹ã
ã«ææã§ãã€ãŠãããã該ããªãšã¹ãã«ææã¯ã
ç±³åœç¹èš±ç¬¬4045031å·ã®æ瀺ã«åŸã€ãŠã€ããããš
ãã§ããã æ¬çºæã®è¡æ¶²ããã°ã¯ãããŠãŒãã«ãã€ãŠé£çµ
ããè€æ°ã®è¡æ¶²ããã°ãå«ããã«ããã«ããã°ã·
ã¹ãã ãžçµã¿èŸŒãã®ãæãŸããã ãã®ä»£ãã«ãæ¬çºæã®çµæç©ãããã³ãããã
ã€ãã€ãããã°ããã³å»ççšããŠãŒããã®ä»ã®åš
å ·ã¯ãåè¿°ããããã«ãžã€ãœããã«ãã¿ã¬ãŒãã®
ãããªè¡æ¶²ã§æœåºãåŸã溶è¡é²æ¢å€ã§å¯å¡åãã
ãä»ã®å¡©çŽ äžå«ãã©ã¹ããã¯ææãããªã€ãŠããŠ
ãããããã®ç®çã«å¯Ÿããåè£ããªããŒææã¯ã
éæ¯æ§ããªãŠã¬ã¿ã³ããã€ãã³ã®ãããªããªã¢ã
ãææãããªã«ãŒãããŒããããªã¹ã«ãã³ãããª
ã¢ã¯ãªã¬ãŒããããªé ¢é žãããŒã«ãããã³ãšãã¬
ã³ããªã¢ã¯ãªã¬ãŒãã®ãããªããããšä»ã®ããªã
ãŒæäŸãšã®å ±éåäœïŒç¹ã«ããããã·åããªã¢ã¯
ãªã¬ãŒãã®ãããªèŠªæ°Žæ§ã®ãã®ïŒãããã³ããªã
ãŒææäžã§è¡æ¶²ã§æœåºãåŸã溶è¡é²æ¢å€ã®å®å®ãª
åºæº¶äœãŸãã¯åæ£äœã圢æãåŸãã䜿çšããè¡æ¶²
ã§æœåºãåŸã溶è¡é²æ¢å€ãšååã«å ±åãåŸãä»ã®
ãã©ã¹ããã¯ææãå«ãã å³é¢ãåç §ãããšã第ïŒå³ã¯æ¬çºæã«ãã€ãŠè£œ
äœããè¡æ¶²ããã°ã®å¹³é¢å³ã§ããã è¡æ¶²ããã°ïŒïŒã¯ãåšå²ã§ã·ãŒã«ããäžå¯Ÿã®ã
ã©ã¹ããã¯ã·ãŒããå«ã¿ããããŠæ®éã®æ¡è¡éã
æã€ãŠããæ¡è¡ããŠãŒãïŒïŒïŒãããæ¬çºæã®çµ
æç©ã§ã€ããããšãã§ããïŒãšããããŠã·ãŒã«ã
ãå°éå£ïŒïŒã®äžå¯Ÿãå«ãæ®éã®æ§é ã«ã€ããã
ãšãã§ããã æ¬çºæã«ããã°ãããã°ïŒïŒã¯ããžã€ãœããã«
ãã¿ã¬ãŒããŸãã¯ããªâïŒâãšãã«ããã·ã«ãã¹
ããšãŒãã®ãããªè¡æ¶²ã§æœåºãåŸãå¯å¡å€ããã³
溶è¡é²æ¢å€ã®çŽ20ãªãã30ééïŒ ãå«ããéæãª
å¯ææ§ã®æ» èãåŸãããããŠå¥œãŸããã¯ãªãŒãã¯
ã¬ãŒãæ» èãåŸãææã§ã€ãããããç¹ã«è¡æ¶²ã§
æœåºãåŸãå¯å¡å€ãå«æãããã©ã¹ããã¯ææ
ã¯ãåè¿°ããããªãšã¹ãã«çµæç©ãšããããšãã§
ãããè¡æ¶²ã§æœåºãåŸãå¯å¡å€ãçŽ20ééïŒ å«æ
ãããããªè¡æ¶²ããã°ã¯ãåãããªãšã¹ãã«ææ
ã®è¡æ¶²ã§æœåºãåŸãå¯å¡å€ãå«ãŸãªãããã°ãžè¡
液ãæ¡åãããããŠåãæ¡ä»¶ã§è²¯èµããå Žåãšæ¯
èŒãããšããæ®éã®æ¡ä»¶ã§ãã®ããã°äžã«21æ¥é
貯èµããè¡æ¶²ã®è¡æŒ¿ãã¢ã°ããã³ã®å®è³ªçæžå°ã
çèµ·ãããããšãã§ããããã®ãããªããã°ã¯ã
ããã°ã液ç¶ã®ãè¡æ¶²ã§æœåºãåŸãå¯å¡å€å Œæº¶è¡
é²æ¢å€äžãžæµžæŒ¬ããããšã«ãã€ãŠã€ããããšãã§
ããã ææã«ãããä»»æã®ãã©ã¹ããã¯ã€ã³ãµãŒãïŒ
ïŒãããã°äžãžæ¿å ¥ããããšãã§ãããã€ã³ãµãŒ
ãïŒïŒã¯ããã°ïŒïŒãšåæ§ãªææãããŸãã¯ãã
ã§äœ¿çšããææã®è¡æ¶²ã§æœåºãåŸãå¯å¡å€å Œæº¶è¡
é²æ¢å€ãšå ±åãåŸãå¥ã®ãã©ã¹ããã¯ææã§ã€ã
ãããšãã§ãããåŸã€ãŠããã°ïŒïŒã®ææã¯çžå¯Ÿ
çã«ææã®è¡æ¶²ã§æœåºãåŸãå¯å¡å€ãå«ãŸãªã
ãããããããã°äžã®ã€ã³ãµãŒãã¯ãããã°ïŒïŒ
äžã«å容ãããè¡æ¶²ãžæœåºãåŸãå¯å¡å€ãäŸçµŠã
ãã®ã«æãŸããã©ããªéã®ã奜ãŸããã¯15ãªãã
70ééïŒ ã®å¯å¡å€ãæ æããããšãã§ãããæ¬çº
æã®æãŸããå¹æã¯ãã®ä»£æ¿æè¡ã«ãã€ãŠéæã§
ããããšãå€æããã ã€ã³ãµãŒãïŒïŒã¯äžæã®ã·ãŒãããŸãã¯å€æ°ã®
ãã©ã¹ããã¯ããŒãºããŸãã¯ä»ã®ã©ããªäŸ¿å©ãªæ§
é ã§ããããäŸãã°ãã®ç¹å®ã®å Žåã§ã¯ãè¡æ¶²ã
ãã°ïŒïŒã¯äžè¬ã«è¡æ¶²ã§æœåºãåŸãå¯å¡å€ãå«ãŸ
ãªãå¯ææ§ã®ã€ã¶ãåŸããã©ã¹ããã¯ææã§ã€ã
ããããŸãã¯ææã«ãããã®ãããªå¯å¡å€ãå«ã
ã§ããŠãããããã®å Žåã«è¡æ¶²ããã°ãããã§ã€
ããåŸãç¹å®ã®ãã©ã¹ããã¯ææã¯ãåè¿°ããã
ãªããŒã®ã»ãã«ãããªãšãã¬ã³ãããªãããã¬
ã³ããŸãã¯ç±³åœç¹èš±ç¬¬4140162å·ã«èšèŒã®ããªãª
ã¬ãã€ã³ãããã¯å ±éåäœçµæç©ã®ãããªããªãª
ã¬ãã€ã³ãå«ãã æ¬åºé¡äººã¯å ã«ããžãªã¯ãã«ãã¿ã¬ãŒãããã³
ãžãªã¯ãã«ã¢ãžããŒããå¡©çŽ äžå«ãã©ã¹ããã¯äž
ã«å«æããããã©ã¹ããã¯çµæç©ããã³ããã䜿
çšããè¡æ¶²ããã°ã®ãããªå»ççšåšå ·ã«ã€ããŠç¹
èš±åºé¡ããïŒç¹é¡æ54â118679å·ãå54â118680
å·ïŒã ãã®åŸãžãªã¯ãã«ãã¿ã¬ãŒãããã³ãžãªã¯ãã«
ã¢ãžããŒã以å€ã«ãããããšåã溶è¡é²æ¢å¹æã
ããããšãçºèŠããããã«ããã溶è¡é²æ¢å€ã¯ãš
ãã«ãžãšã³ã®åœ¢ã§äœ¿çšã§ãããšã®ç¥èŠãåŸãŠæ¬çº
æã«è³ã€ããã®ã§ããã 以äžã®å®æœäŸã¯äŸèšŒç®çã®ã¿ã«æäŸããããã®
ã§ãã€ãŠãç¹èš±è«æ±ã®ç¯å²èšèŒã®æ¬çºæãéå®ã
ãããšãæå³ãããã®ã§ã¯ãªãã å®æœäŸ ïŒ Tween80ïŒããªãœã«ããŒã80ïŒïŒmlãšã以äžã®
åç©è³ªïŒmlãšãããšãã«ãžãšã³ã補é ããã ãžâïŒâãšãã«ããã·ã«ãã¿ã¬ãŒã ãžãªã¯ãã«ãã¬ãã¿ã¬ãŒã ããªâïŒâãšãã«ããã·ã«ããªã¡ãªããŒã Tween80ãåãšã¹ãã«ãšæ··åããåŸãåæ··å
ç©0.3mlãç¡èã®0.9ééïŒ é£å¡©æ°Ž150mlãžãããŸ
ããªããå ããå®å®ãªãšãã«ãžãšã³ã補é ããã åãšãã«ãžãšã³0.5mlãå¥ã ã®ããªãããã¬ã³
è©Šéšç®¡ãžãããæ··åãããå ¬ç¥ã®CPDã§ååºé²
æ¢ããæ°ãã«æ¡è¡ããããå šè¡7.5mlãšãšãã«å
ããã è¡æ¶²ã¯ãè¡æ¶²ãšæµžåºãåŸãå¯å¡å€ãšã®æ©ææ¥è§Š
ãé¿ããããã«ãé浞åºæ§å¯å¡å€ã§ããããªâïŒ
âãšãã«ããã·ã«ããªã¡ãªããŒãã§å¯å¡åããã
ãã«è¡æ¶²ããã°äžãžãäŸè¡è ããåžåŒããã ããªãããã¬ã³è©Šéšç®¡ã¯ã¹ããããŒã§èããã
åŸïŒåå転ããïŒâã§21æ¥éå·èµããã äºæ¬ã®å¯Ÿç §ããŠãŒãã¯ãå¯Ÿç §No.ïŒãšããŠãè¡æ¶²
ã®ã¿ãå ¥ããããŠãŒããšããããŠå¯Ÿç §No.ïŒãšã
ãŠãè¡æ¶²ããã³é£å¡©æ°Žäžå¯Ÿå¿æ¿åºŠã®Tween80ã
å容ããããŠãŒããšãçšæããã 21æ¥åŸãåãµã³ãã«ã®è¡æŒ¿ãã¢ã°ããã³å«éã
枬å®ãããã®çµæã以äžã®ç¬¬ïŒè¡šã«ç€ºãã
äŸãã°ããã¯ããèµ€è¡çãè¡æŒ¿ãè¡å°æ¿ããã³å¯
æ§æ²ãã³ãåŸãããã«ç¡èæ¡ä»¶äžã§è¡æ¶²ãæ¡é
ããåŠçããããã«ãã¯ã¹ã¿ãŒããã©ãããŒã«ã
ã©ãã©ããªãŒãºãã€ã³ã³ãŒãã¬ã€ãããã®ããšã³
ãŠãªãŒã«éšéããåžè²©ãããŠããã çŸåšå ¥æãåŸãè¡æ¶²ããã¯ã¯ããšã¹ãã«ã¿ã€ã
ã®å¯å¡å€ãšããŠãžâïŒâãšãã«ããã·ã«ãã¿ã¬ãŒ
ããå«ãããªå¡©åããã«çµæç©ããã§ããŠããã
ããªå¡©åããã«èªäœã¯å®¹åšãšããŠäœ¿çšããããã«
é©åœãªå¯ææ§ãã©ã¹ããã¯ææã§ã¯ãªãã®ã§ãã
ã®ãããªå¯å¡å€ã¯ããªå¡©åããã«çµæç©ã«ã¯çµ¶å¯Ÿ
å¿ èŠã§ããããã®ãããªè¡æ¶²ããã°ã¯è¡æ¶²ããã³
è¡æ¶²æåã®è²¯èµããã³åŠçã«æ¥µããŠè¯ã圹ç«ã¡ã
äŸãã°21æ¥è²¯èµåŸã«ãããŠäœãè¡æŒ¿ãã¢ã°ããã³
å«éã®ããšã«é«ãçåçã瀺ããŠæ¥ãã è¡æ¶²ããã°ææã®åè£ãšããŠå¯ææ§ããªãšã¹ã
ã«ãããªãªã¬ãã€ã³ãªã©ãå«ãä»ã®å¡©çŽ äžå«ãã©
ã¹ããã¯çµæç©ãè©Šéšããããé©ãã¹ãããšã«ã
è©Šéšããææã®å€æ°ã¯ãè¡æ¶²ããã°ã®è£œäœã«è¯ã
ãã©ã¹ããã¯ææã§ããããšã®æ瀺ãäžãããã
ã©ããæ®éã®è¡æ¶²è²¯èµæ¡ä»¶äžã«ãã®ãããªææã§
ã€ãã€ã容åšäžã«è²¯èµããè¡æ¶²ããäŸãã°21æ¥è²¯
èµåŸå¥œãŸãããªãé«ãè¡æŒ¿ãã¢ã°ããã³å«éã瀺
ãããšãçããããèµ€è¡çã®æº¶è§£çãé«ãããšã
瀺ããã æ¬çºæã«ããã°ãé©ãã¹ãããšã«ããçš®ã®ãšã¹
ãã«ã¿ã€ãã®å¯å¡å€ã®ååšã¯ããã®ãããªãšã¹ã
ã«ã¿ã€ãã®å¯å¡å€ãå«ãŸãªãåãæ§ãªãã©ã¹ãã
ã¯ææããã€ãã€ã容åšãšæ¯èŒããŠãè¡æ¶²ãé·æ
é貯èµããéè¡æŒ¿ãã¢ã°ããã³å«éã®èããäœäž
ãçããããããšãçºèŠãããããã®ããšã¯ç°ãª
ã€ãå©çããã³ææã®æ§è³ªãæã€ããããããã
ã«ããããããåžè²©ã®ããªå¡©åããã«çµæç©ã§ä»
ã®ãšããå®çŸå¯èœãªã®ãšåæ§ã«é·æé貯èµäžå¥œãŸ
ããäœã溶è¡çã瀺ãå¡©çŽ äžå«ãã©ã¹ããã¯çµæ
ç©ã§ã€ãã€ãè¡æ¶²ããã°ããã³ãã®ä»ã®è¡æ¶²ãšæ¥
觊ããå»çå ·ãæäŸããããšã«å©çšããããšãã§
ããã æ¬çºæã«ããã°ãå°éããŠãŒãããã³ã·ãŒã«ã
ãå°éå£ãããªããã·ãŒã«ããå¯ææ§ã®éæãªå®¹
åšãããªãè¡æ¶²ããã°ãŸãã¯ãã®é¡äŒŒç©ãæäŸã
ãããè¡æ¶²ã¯ãå¯ææ§ã®è¡æ¶²ãšå ±åãåŸããæ» è
å¯èœãªå¡©çŽ äžå«ãã©ã¹ããã¯çµæç©ãããªããã
ã®äžã«åæ£ãããäŸãã°çåæ°ŽçŽ éäžã«ãããã
ïŒãªãã12åã®ççŽ ååã®èèªæçåæ°ŽçŽ åºãå«
ãå°ãªããšãäºã€ã®ãšã¹ãã«çµåãå«ãèèªæãš
ã¹ãã«ãããªããè¡æ¶²ã§æœåºãåŸãç©è³ªã奜ãŸã
ãã¯ïŒãªãã70ééïŒ ãå«ããã©ã¹ããã¯çµæç©
ãããªãããã°äžã«äœæ¥éãä¿åããããšãã§ã
ãã ãšã¹ãã«çµåïŒäŸãã°ïŒ¯ â âOCâïŒäžã® èèªæçåæ°ŽçŽ åºã¯ã奜ãŸããã¯ççŽ æ°ïŒãªãã
10ã®ã¢ã«ãã«åºã§ããããšã¹ãã«çµåã¯ã奜ãŸã
ãã¯éã®äºãã«é£æ¥ããççŽ ååãžçµåãããã
ãããããçåæ°ŽçŽ åºãé«åºŠã«äŒžçž®æ¯åæ§ãäŸã
ã°ãžâïŒâãšãã«ããã·ã«ã¢ãžããŒãäžã®é£œåçŽ
éçåæ°ŽçŽ éã®ããã§ããã°ããã€ãšé ãé¢ãã
ãšã¹ãã«åºãããè¯ãçµæãåŸãããšãã§ããã ãšã¹ãã«çµåã®èèªæçåæ°ŽçŽ åºã®äŸã¯ããªã¯
ãã«ããããã«ãããã«ããã·ã«ãŸãã¯ïŒâãšã
ã«ããã·ã«ã®ãããªå¥œãŸããã¢ã«ãã«åºã§ããã
奜ãŸããã¯ã該èèªæçåæ°ŽçŽ åºã¯åå²ããŠã
ããããã·ã«ããã³ããã·ã«ã®ãããªä»ã®åºããŸ
ã䜿çšã§ããããŸããäžé£œåçµåãäžã€ãŸãã¯äº
ã€ä»¥äžå«ããªã¯ããã«ããããã«ãŸãã¯ãã»ãã«
ã®ãããªé¡äŒŒã®ã¢ã«ã±ãã«åºã䜿çšã§ããã ãšã¹ãã«ç©è³ªã®äŸã¯ããžã€ãœããã«ãã¿ã¬ãŒã
ããã³ãžã€ãœãã·ã«ãã¿ã¬ãŒãã§ããã䜿çšãåŸ
ãä»ã®æº¶è¡é²æ¢å€ã¯ããžâïŒâãšãã«ããã·ã«ã
ã¬ãšãŒãããžããã«ãã¿ã¬ãŒãããžããã·ã«ãã¿
ã¬ãŒãããžããã·ã«ãã¿ã¬ãŒãããžâïŒâãšãã«
ããã·ã«ã¢ã¶ã¬ãŒãããžâïŒâãšãã«ããã·ã«ã€
ãœãã¿ã¬ãŒããããã³ãžâïŒâãšãã«ããã·ã«ã
ã¬ãšãŒããå«ã¿ãããããã¹ãŠã¯è¡æ¶²ãšã®åæ£æ¥
觊ã«ãããŠæº¶è¡é²æ¢å¹æãçºæ®ããããšã¹ãã«å
溶è¡é²æ¢å€ã®ãšãã«ãžãšã³ãæ·»å ããããšãã§ã
ãã äŸãã°ãè¡æ¶²ã¯ã溶è¡é²æ¢å€äŸãã°äžèšã®ã¿ã€
ãã®èèªæãšã¹ãã«ã®ãšãã«ãžãšã³ãããšãã«ãž
ãšã³ã®äžååšäžã®åæ§ã®è²¯èµæ¡ä»¶ã«ãããè¡æ¶²ãš
æ¯èŒãããšãã貯èµããè¡æ¶²äžã®æº¶è¡ã®æžå°ãç
ããããã®ã«å åãªéã«ãããŠå容ãããè¡æ¶²ãš
å ±åãåŸã容åšäžã«äœæž©ã«ãããŠïŒæ¥ä»¥äžã®æé
çäœå€ã§è²¯èµããããšãã§ããã 奜ãŸããã¯ã該ãšãã«ãžãšã³ã¯è¡æ¶²ãšå ±åãåŸ
ãçé¢æŽ»æ§å€ãã該ãšãã«ãžãšã³ãäžå®æéãå°
ãªããšãè¡æ¶²ã®è²¯èµæéã®éå®å®åããã®ã«å å
ãªéå«æãããå¿è«æ°žä¹ ã«å®å®ãªãšãã«ãžãšã³ã
奜ãŸããããã®ãããªãšãã«ãžãšã³ã¯ãäžè¬ã«æº¶
è¡é²æ¢å€ãäŸãã°åèšã®èèªæãšã¹ãã«ãšãè¡æ¶²
ãšå ±åãåŸãçé¢æŽ»æ§å€ãšããå®è³ªäžæ°Žã®äžååš
äžã«æ··åããããšã«ãã€ãŠè£œé ãåŸããç·å¯ã«æ··
ååŸãåŸãããæ··åç©ãæ°Žæåãžæ·»å ããšãã«ãž
ãšã³ã圢æãããããã®ãšãã«ãžãšã³ã¯ä»ã®ãšã
ã«ãžãšã³åæè¡ããã®çµæãšå察ã«ãæ°žä¹ ã«å®å®
ã§ããã ããã«ä»£ããŠãã©ã¹ããã¯å®¹åšææèªäœãäŸã
ã°å¯ææ§ã®è¡æ¶²ãšå ±åãåŸãæ» èå¯èœãªå¡©çŽ äžå«
ãã©ã¹ããã¯çµæç©ãã該ãã©ã¹ããã¯ããã°æ
æã®çµæã®äžéšãšããŠã溶è¡é²æ¢å€ã®å šéšãŸãã¯
äžéšãå«æããŠããŠããããäŸãã°ã該ãã©ã¹ã
ãã¯ææã¯ããã®äžãžåæ£ãã溶è¡é²æ¢å€ã®15ãª
ãã40ééïŒ ãããã©ã¹ããã¯ããã°ææãšè¡æ¶²
ãšã®é·æéã®æ¥è§Šã«ãã€ãŠæº¶è¡é²æ¢å€ã貯èµæé
äžè¡æ¶²äžãžæµžåºãããããªæ æ§ã§å«æããããšã
ã§ããã ããã«æ¬çºæã«ãããŠäœ¿çšãããèèªæãšã¹ã
ã«ã¯ã奜ãŸããã¯ççŽ ååïŒãªãã12ã®èèªæãš
ã¹ãã«çµåãåããªã³ååãžçµåããŠãããªã³é ž
ãšã¹ãã«ã§ããããäŸãã°ããªãªã¯ãã«ãã¹ããš
ãŒãã䜿çšããããšãã§ããã 䜿çšããããšãã§ããä»ã®æº¶è¡é²æ¢å€ã¯ãããª
ãšãã«ããã·ã«ããªã¡ãªããŒãã®ãããªãšãã«ãž
ãšã³ã®åœ¢ã§æŽ»æ§ã瀺ãäžå®èœæ§ãšã¹ãã«ãšããã
ãŠãã¯ããšãã«ãžãšã³ã®åœ¢ã§æŽ»æ§ã瀺ãããªãªã¯
ãã«ãã¬ãã¿ã¬ãŒãã®ãããªèèªæãšã¹ãã«åºã
ççŽ ååäžã§é£æ¥ããªãä»ã®ãšã¹ãã«ãå«ãã äžè¬ã«æº¶è¡é²æ¢å€ã¯ã溶è¡é²æ¢å€ãšè¡æ¶²ãšã®é
ã§æ¡æ£äº€æããã€ãããšè¡ãããããã«é«åºŠã«å
æ£ãã溶è¡é²æ¢å€ã貯èµè¡æ¶²ãšæ¥è§Šãããããšã«
ãã€ãŠæå¹ãšãªãåŸãããšãã«ãžãšã³ã¯ãè¡æ¶²äž
奜ãŸããã¯50ãªãã100ppmã®æ¿åºŠãäžãããã
ã«æ£ç¢ºã«å¶åŸ¡ãããéã®æº¶è¡é²æ¢å€ãæ·»å ããã
ãšãã§ããã®ã§ãããã«äœ¿çšãããšãã«ãžãšã³ã
奜ãŸããã溶è¡é²æ¢å€ãè¡æ¶²ãžæ·»å ããä»ã®å€§ãŸ
ããªæè¡ã¯ãç¹ã«è¡æ¶²è²¯èµã®æåã®æ°æ¥éã«ãã
ãŠãè¡æ¶²çžãžç§»è¡ãã溶è¡é²æ¢å€ã®äžå åãªéã
çãåŸããä»æ¹æº¶è¡é²æ¢å€ã®å€§ãŸããªéå°ã¯ãè¡
液ã容åšãžæ·»å ããåã«å®¹åšã®åŽé¢ã溶è¡é²æ¢å€
ã§ã³ãŒãã€ã³ã°ãããããªãå¶åŸ¡ãããªãæè¡ã«
ãã€ãŠè¡æ¶²äžãžç§»è¡ãããããšãã§ããã ããã«äŸãã°ãI.C.I.ã¢ã¡ãªã«ã¹ç€Ÿãã販売ã®
Tween80ã®ãããªããœã«ãã¿ã³ç¡æ°Žç©ã®æ··åéš
åãªã¬ã€ã³é žãšã¹ãã«ã®ããªãªãã·ãšãã¬ã³ãšãŒ
ãã«ã®è€åæ··åç©ã§ããããªãœã«ããŒã80ïŒç±³åœ
è¬å±æ¹ïŒã®ãããªãã©ã®ãããªè¡æ¶²ãšå ±åãåŸã
éæ¯æ§ä¹³åå€ã䜿çšããŠããããä»ã®é©åœãªä¹³å
å€ã¯ãå瀟ããTween40ã®å称ã§è²©å£²ãããŠã
ããããªãªãã·ãšãã¬ã³ïŒ20ïŒãœã«ãã¿ã³ã¢ãã
ã«ãããŒãã§ãããä»ã®äœ¿çšãåŸãä¹³åå€ã¯ã³ã¬
ã¹ãããŒã«ããã³ã¬ã·ãã³ãå«ã¿ããããã¯éåžž
äœå ã«èŠåºãããã®ã§æå©ã§ããã 䜿çšã«éããæ¬çºæã®ãšãã«ãžãšã³ã¯ãCPD
ãŸãã¯ACDã®ãããªéåžžè¡æ¶²ããã°äžã«èŠãã
ãä¿åæ é€å€ãšäžæã«æ®éã®è¡æ¶²ããã°äžãžå ã
ãããã ããã°äžã®æº¶è¡é²æ¢å€ã®æ¿åºŠããã³ååžã¯ãã
ãã°ãžè¡æ¶²ãå å¡«ããŠé·æéä¿åãããšããè¡æ¶²
äžã®æº¶è¡é²æ¢å€ã®æ¿åºŠã21æ¥éã«ããã€ãŠå žåç
ã«ã¯è¡æ¶²ïŒmlåœãçŽ30ãªãã100ÎŒgããããŠå¥œãŸ
ããã¯50ãªãã80ÎŒgãžäžæãããããªãã®ã§ã
ãããšãç¹ã«æãŸãããããã¯æº¶è¡é²æ¢å€ããã©
ã¹ããã¯ææããè¡æ¶²ãžæº¶è§£ãã圢ã§æœåºããã
ããã«ãããåŸãã ããæããªãã°ãå容ãããè¡æ¶²ãšæ¥è§Šããã
ãã°ææã®äžéšã®ã¿ãæ¬çºæã®æº¶è¡é²æ¢å€ãå«æ
ããŠããããã奜ãŸããã¯å šäœã®ããã°ææã溶
è¡é²æ¢å€ãå«æããããã®ä»£ãã«ãã©ã¹ããã¯ã®
ã·ãŒãããã©ã¹ããã¯ã®ããŒãºãã®ä»ã®ãããªã
ã©ã¹ããã¯ã€ã³ãµãŒããè¡æ¶²ããã°å ã«ååšã
ãããããŠè©²ã€ã³ãµãŒãã溶è¡é²æ¢å€ãå«æãã
å®éã®ããã°å£ã¯æ¯èŒçãã®ãããªæº¶è¡é²æ¢å€ã
å«ãŸãªãããã«ããŠãããããããäž¡æ¹ã®å Žåãš
ããäžè¬çã«å®è³ªäžããã°å šäœã®ææã«è¡æ¶²ã§æœ
åºãåŸã溶è¡é²æ¢å€ã®å¥œãŸãã䜿çšãšåçã§ã
ãã å¯å¡å€ãšããŠãäœçšãåŸãè¡æ¶²ã§æœåºãåŸã溶
è¡é²æ¢å€ã¯ã奜ãŸããã¯å¯ææ§ããã°å£äžã«ïŒãª
ãã50ééïŒ ãããã³å žåçã«ã¯çŽ15ãªãã40é
éïŒ ååšããã ãã©ã¹ããã¯ã€ã³ãµãŒãã䜿çšãããšãã¯ãã€
ã³ãµãŒãäžã®è¡æ¶²ã§æœåºãåŸã溶è¡é²æ¢å€ã®æ¿åºŠ
ã¯ãææã«ããçŽ70ïŒ ãŸã§é«ããããšãã§ããã
ããã¯ã€ã³ãµãŒãã¯éåžžæ§é æã§ã¯ãªãããããŠ
é«ãåŒåŒµã匷床ãæã€å¿ èŠããªãããã§ããã äžè¿°ã®è¡æ¶²ããã°ã®äœ¿çšã¯ã溶è¡é²æ¢å€ãå«ãŸ
ãªã察å¿ããããã°äžã«ãããŠåãæ¡ä»¶ã§è²¯èµã
ãè¡æ¶²ãšæ¯èŒãããšããæ®éã®æ¡ä»¶ã§21æ¥é貯èµ
ããè¡æ¶²ã«ãã€ãŠçæãããè¡æŒ¿ãã¢ã°ããã³ã®
å®è³ªçãªæžå°ãããããããšãã§ããã ããæããªãã°ãæ¬çºæã®çµæã¯å»ççšããŠãŒ
ãããã³ãã®ä»ã®åšå ·ã補é ããããã«äœ¿çšãã
ããšãã§ããã æ¬çºæã«äœ¿çšãããææã¯ãå Žåã«ãã€ãŠæœåº
ãåŸã溶è¡é²æ¢å€ã®ææéãå«æããããªãšã¹ã
ã«ææã§ãã€ãŠãããã該ããªãšã¹ãã«ææã¯ã
ç±³åœç¹èš±ç¬¬4045031å·ã®æ瀺ã«åŸã€ãŠã€ããããš
ãã§ããã æ¬çºæã®è¡æ¶²ããã°ã¯ãããŠãŒãã«ãã€ãŠé£çµ
ããè€æ°ã®è¡æ¶²ããã°ãå«ããã«ããã«ããã°ã·
ã¹ãã ãžçµã¿èŸŒãã®ãæãŸããã ãã®ä»£ãã«ãæ¬çºæã®çµæç©ãããã³ãããã
ã€ãã€ãããã°ããã³å»ççšããŠãŒããã®ä»ã®åš
å ·ã¯ãåè¿°ããããã«ãžã€ãœããã«ãã¿ã¬ãŒãã®
ãããªè¡æ¶²ã§æœåºãåŸã溶è¡é²æ¢å€ã§å¯å¡åãã
ãä»ã®å¡©çŽ äžå«ãã©ã¹ããã¯ææãããªã€ãŠããŠ
ãããããã®ç®çã«å¯Ÿããåè£ããªããŒææã¯ã
éæ¯æ§ããªãŠã¬ã¿ã³ããã€ãã³ã®ãããªããªã¢ã
ãææãããªã«ãŒãããŒããããªã¹ã«ãã³ãããª
ã¢ã¯ãªã¬ãŒããããªé ¢é žãããŒã«ãããã³ãšãã¬
ã³ããªã¢ã¯ãªã¬ãŒãã®ãããªããããšä»ã®ããªã
ãŒæäŸãšã®å ±éåäœïŒç¹ã«ããããã·åããªã¢ã¯
ãªã¬ãŒãã®ãããªèŠªæ°Žæ§ã®ãã®ïŒãããã³ããªã
ãŒææäžã§è¡æ¶²ã§æœåºãåŸã溶è¡é²æ¢å€ã®å®å®ãª
åºæº¶äœãŸãã¯åæ£äœã圢æãåŸãã䜿çšããè¡æ¶²
ã§æœåºãåŸã溶è¡é²æ¢å€ãšååã«å ±åãåŸãä»ã®
ãã©ã¹ããã¯ææãå«ãã å³é¢ãåç §ãããšã第ïŒå³ã¯æ¬çºæã«ãã€ãŠè£œ
äœããè¡æ¶²ããã°ã®å¹³é¢å³ã§ããã è¡æ¶²ããã°ïŒïŒã¯ãåšå²ã§ã·ãŒã«ããäžå¯Ÿã®ã
ã©ã¹ããã¯ã·ãŒããå«ã¿ããããŠæ®éã®æ¡è¡éã
æã€ãŠããæ¡è¡ããŠãŒãïŒïŒïŒãããæ¬çºæã®çµ
æç©ã§ã€ããããšãã§ããïŒãšããããŠã·ãŒã«ã
ãå°éå£ïŒïŒã®äžå¯Ÿãå«ãæ®éã®æ§é ã«ã€ããã
ãšãã§ããã æ¬çºæã«ããã°ãããã°ïŒïŒã¯ããžã€ãœããã«
ãã¿ã¬ãŒããŸãã¯ããªâïŒâãšãã«ããã·ã«ãã¹
ããšãŒãã®ãããªè¡æ¶²ã§æœåºãåŸãå¯å¡å€ããã³
溶è¡é²æ¢å€ã®çŽ20ãªãã30ééïŒ ãå«ããéæãª
å¯ææ§ã®æ» èãåŸãããããŠå¥œãŸããã¯ãªãŒãã¯
ã¬ãŒãæ» èãåŸãææã§ã€ãããããç¹ã«è¡æ¶²ã§
æœåºãåŸãå¯å¡å€ãå«æãããã©ã¹ããã¯ææ
ã¯ãåè¿°ããããªãšã¹ãã«çµæç©ãšããããšãã§
ãããè¡æ¶²ã§æœåºãåŸãå¯å¡å€ãçŽ20ééïŒ å«æ
ãããããªè¡æ¶²ããã°ã¯ãåãããªãšã¹ãã«ææ
ã®è¡æ¶²ã§æœåºãåŸãå¯å¡å€ãå«ãŸãªãããã°ãžè¡
液ãæ¡åãããããŠåãæ¡ä»¶ã§è²¯èµããå Žåãšæ¯
èŒãããšããæ®éã®æ¡ä»¶ã§ãã®ããã°äžã«21æ¥é
貯èµããè¡æ¶²ã®è¡æŒ¿ãã¢ã°ããã³ã®å®è³ªçæžå°ã
çèµ·ãããããšãã§ããããã®ãããªããã°ã¯ã
ããã°ã液ç¶ã®ãè¡æ¶²ã§æœåºãåŸãå¯å¡å€å Œæº¶è¡
é²æ¢å€äžãžæµžæŒ¬ããããšã«ãã€ãŠã€ããããšãã§
ããã ææã«ãããä»»æã®ãã©ã¹ããã¯ã€ã³ãµãŒãïŒ
ïŒãããã°äžãžæ¿å ¥ããããšãã§ãããã€ã³ãµãŒ
ãïŒïŒã¯ããã°ïŒïŒãšåæ§ãªææãããŸãã¯ãã
ã§äœ¿çšããææã®è¡æ¶²ã§æœåºãåŸãå¯å¡å€å Œæº¶è¡
é²æ¢å€ãšå ±åãåŸãå¥ã®ãã©ã¹ããã¯ææã§ã€ã
ãããšãã§ãããåŸã€ãŠããã°ïŒïŒã®ææã¯çžå¯Ÿ
çã«ææã®è¡æ¶²ã§æœåºãåŸãå¯å¡å€ãå«ãŸãªã
ãããããããã°äžã®ã€ã³ãµãŒãã¯ãããã°ïŒïŒ
äžã«å容ãããè¡æ¶²ãžæœåºãåŸãå¯å¡å€ãäŸçµŠã
ãã®ã«æãŸããã©ããªéã®ã奜ãŸããã¯15ãªãã
70ééïŒ ã®å¯å¡å€ãæ æããããšãã§ãããæ¬çº
æã®æãŸããå¹æã¯ãã®ä»£æ¿æè¡ã«ãã€ãŠéæã§
ããããšãå€æããã ã€ã³ãµãŒãïŒïŒã¯äžæã®ã·ãŒãããŸãã¯å€æ°ã®
ãã©ã¹ããã¯ããŒãºããŸãã¯ä»ã®ã©ããªäŸ¿å©ãªæ§
é ã§ããããäŸãã°ãã®ç¹å®ã®å Žåã§ã¯ãè¡æ¶²ã
ãã°ïŒïŒã¯äžè¬ã«è¡æ¶²ã§æœåºãåŸãå¯å¡å€ãå«ãŸ
ãªãå¯ææ§ã®ã€ã¶ãåŸããã©ã¹ããã¯ææã§ã€ã
ããããŸãã¯ææã«ãããã®ãããªå¯å¡å€ãå«ã
ã§ããŠãããããã®å Žåã«è¡æ¶²ããã°ãããã§ã€
ããåŸãç¹å®ã®ãã©ã¹ããã¯ææã¯ãåè¿°ããã
ãªããŒã®ã»ãã«ãããªãšãã¬ã³ãããªãããã¬
ã³ããŸãã¯ç±³åœç¹èš±ç¬¬4140162å·ã«èšèŒã®ããªãª
ã¬ãã€ã³ãããã¯å ±éåäœçµæç©ã®ãããªããªãª
ã¬ãã€ã³ãå«ãã æ¬åºé¡äººã¯å ã«ããžãªã¯ãã«ãã¿ã¬ãŒãããã³
ãžãªã¯ãã«ã¢ãžããŒããå¡©çŽ äžå«ãã©ã¹ããã¯äž
ã«å«æããããã©ã¹ããã¯çµæç©ããã³ããã䜿
çšããè¡æ¶²ããã°ã®ãããªå»ççšåšå ·ã«ã€ããŠç¹
èš±åºé¡ããïŒç¹é¡æ54â118679å·ãå54â118680
å·ïŒã ãã®åŸãžãªã¯ãã«ãã¿ã¬ãŒãããã³ãžãªã¯ãã«
ã¢ãžããŒã以å€ã«ãããããšåã溶è¡é²æ¢å¹æã
ããããšãçºèŠããããã«ããã溶è¡é²æ¢å€ã¯ãš
ãã«ãžãšã³ã®åœ¢ã§äœ¿çšã§ãããšã®ç¥èŠãåŸãŠæ¬çº
æã«è³ã€ããã®ã§ããã 以äžã®å®æœäŸã¯äŸèšŒç®çã®ã¿ã«æäŸããããã®
ã§ãã€ãŠãç¹èš±è«æ±ã®ç¯å²èšèŒã®æ¬çºæãéå®ã
ãããšãæå³ãããã®ã§ã¯ãªãã å®æœäŸ ïŒ Tween80ïŒããªãœã«ããŒã80ïŒïŒmlãšã以äžã®
åç©è³ªïŒmlãšãããšãã«ãžãšã³ã補é ããã ãžâïŒâãšãã«ããã·ã«ãã¿ã¬ãŒã ãžãªã¯ãã«ãã¬ãã¿ã¬ãŒã ããªâïŒâãšãã«ããã·ã«ããªã¡ãªããŒã Tween80ãåãšã¹ãã«ãšæ··åããåŸãåæ··å
ç©0.3mlãç¡èã®0.9ééïŒ é£å¡©æ°Ž150mlãžãããŸ
ããªããå ããå®å®ãªãšãã«ãžãšã³ã補é ããã åãšãã«ãžãšã³0.5mlãå¥ã ã®ããªãããã¬ã³
è©Šéšç®¡ãžãããæ··åãããå ¬ç¥ã®CPDã§ååºé²
æ¢ããæ°ãã«æ¡è¡ããããå šè¡7.5mlãšãšãã«å
ããã è¡æ¶²ã¯ãè¡æ¶²ãšæµžåºãåŸãå¯å¡å€ãšã®æ©ææ¥è§Š
ãé¿ããããã«ãé浞åºæ§å¯å¡å€ã§ããããªâïŒ
âãšãã«ããã·ã«ããªã¡ãªããŒãã§å¯å¡åããã
ãã«è¡æ¶²ããã°äžãžãäŸè¡è ããåžåŒããã ããªãããã¬ã³è©Šéšç®¡ã¯ã¹ããããŒã§èããã
åŸïŒåå転ããïŒâã§21æ¥éå·èµããã äºæ¬ã®å¯Ÿç §ããŠãŒãã¯ãå¯Ÿç §No.ïŒãšããŠãè¡æ¶²
ã®ã¿ãå ¥ããããŠãŒããšããããŠå¯Ÿç §No.ïŒãšã
ãŠãè¡æ¶²ããã³é£å¡©æ°Žäžå¯Ÿå¿æ¿åºŠã®Tween80ã
å容ããããŠãŒããšãçšæããã 21æ¥åŸãåãµã³ãã«ã®è¡æŒ¿ãã¢ã°ããã³å«éã
枬å®ãããã®çµæã以äžã®ç¬¬ïŒè¡šã«ç€ºãã
ãè¡šã
äžã®å®æœäŸïŒã«åè¿°ããã®ãšåãæ¹æ³ã§ããã«
è¡æ¶²ãµã³ãã«ãè©Šéšã®ããã«ã€ããã28æ¥é貯èµ
ããããã®çµæã以äžã®ç¬¬ïŒè¡šã«ç€ºãã
è¡æ¶²ãµã³ãã«ãè©Šéšã®ããã«ã€ããã28æ¥é貯èµ
ããããã®çµæã以äžã®ç¬¬ïŒè¡šã«ç€ºãã
ãè¡šã
äžçš®ãã¹ãŠã®ãšã¹ãã«ã®ãšãã«ãžãšã³ã溶è¡é²
æ¢å¹æãçºæ®ãããžâïŒâãšãã«ããã·ã«ãã¿ã¬
ãŒãããã€ãšã匷ãå¹æãçºæ®ããããšããã
ãã å®æœäŸ ïŒ äžã®å®æœäŸïŒã®å®éšãç¹°ãè¿ããããã ãåã®
å®æœäŸïŒã®Tween80ãTween40ã§çœ®ãæããã
è¡æ¶²ã¯ãããããžâïŒâãšãã«ããã·ã«ãã¿ã¬ãŒ
ãããã³ããªâïŒâãšãã«ããã·ã«ããªã¡ãªããŒ
ããå«æãããšãã«ãžãšã³ã®çæ¿åºŠã§åŠçãã貯
èµããã 以äžã®ç¬¬ïŒè¡šã¯äºçš®ã®ç°ãªããšã¹ãã«ã®åãšã
ã«ãžãšã³ã«ã€ããŠããããã21æ¥ããã³28æ¥è²¯èµ
åŸã®è¡æ¶²äžã®è¡æŒ¿ãã¢ã°ããã³ã瀺ãã
æ¢å¹æãçºæ®ãããžâïŒâãšãã«ããã·ã«ãã¿ã¬
ãŒãããã€ãšã匷ãå¹æãçºæ®ããããšããã
ãã å®æœäŸ ïŒ äžã®å®æœäŸïŒã®å®éšãç¹°ãè¿ããããã ãåã®
å®æœäŸïŒã®Tween80ãTween40ã§çœ®ãæããã
è¡æ¶²ã¯ãããããžâïŒâãšãã«ããã·ã«ãã¿ã¬ãŒ
ãããã³ããªâïŒâãšãã«ããã·ã«ããªã¡ãªããŒ
ããå«æãããšãã«ãžãšã³ã®çæ¿åºŠã§åŠçãã貯
èµããã 以äžã®ç¬¬ïŒè¡šã¯äºçš®ã®ç°ãªããšã¹ãã«ã®åãšã
ã«ãžãšã³ã«ã€ããŠããããã21æ¥ããã³28æ¥è²¯èµ
åŸã®è¡æ¶²äžã®è¡æŒ¿ãã¢ã°ããã³ã瀺ãã
ãè¡šã
çé¢æŽ»æ§å€ã®å€æŽãé€ããŠåäžæ¡ä»¶ã䜿çšãã
ã®ã§ãåã®å¯Ÿç §æ瞟ã¯ãã®å®éšã«ã€ããŠãæå¹ã§
ãããšä¿¡ããããã å®æœäŸ ïŒ Tween80ïŒããªãœã«ããŒã80ïŒïŒmlãšã第ïŒè¡š
ã«æãããšã¹ãã«åïŒmlãšãããšãã«ãžãšã³ã補
é ããã Tween80ãåãšã¹ãã«ãšæ··åããåŸãåæ··å
ç©0.2mlãç¡èã®0.9ééïŒ é£å¡©æ°Ž83mlãžãããŸã
ãªããå ããå®å®ãªãšãã«ãžãšã³ã補é ãããå
ãšãã«ãžãšã³0.5mlãå¥ã ã®ããªãããã¬ã³è©Šéš
管ãžãããæ··åãããå ¬ç¥ã®CPDã§ååºé²æ¢ã
ãæ°ããªæ¡è¡ããããå šè¡7.5mlãšãšãã«å ããã è¡æ¶²ã¯å®æœäŸïŒèšèŒã®æ¹æ³ã§äŸè¡è ããåžåŒã
ããããªãããã¬ã³è©Šéšç®¡ã¯ã¹ããããŒã§èãã
ãåŸïŒåå転ããïŒâã§21æ¥éå·èµããã äžæ¹ã®å¯Ÿç §ããŠãŒãã¯é£å¡©æ°Žäžå¯Ÿå¿æ¿åºŠã®
Tween80äžã®è¡æ¶²ãå容ãããä»æ¹ã®å¯Ÿç §ããŠ
ãŒãã¯è¡æ¶²ã ããå容ãããããŠãžâïŒâãšãã«
ããã·ã«ãã¿ã¬ãŒãã§å¯å¡åããããªå¡©åãããŒ
ã«çãå ¥ããã 21æ¥åŸãåãµã³ãã«ã®è¡æŒ¿ãã¢ã°ããã³å«éã
枬å®ãã以äžã®ç¬¬ïŒè¡šã«ãã®çµæã瀺ãã
ã®ã§ãåã®å¯Ÿç §æ瞟ã¯ãã®å®éšã«ã€ããŠãæå¹ã§
ãããšä¿¡ããããã å®æœäŸ ïŒ Tween80ïŒããªãœã«ããŒã80ïŒïŒmlãšã第ïŒè¡š
ã«æãããšã¹ãã«åïŒmlãšãããšãã«ãžãšã³ã補
é ããã Tween80ãåãšã¹ãã«ãšæ··åããåŸãåæ··å
ç©0.2mlãç¡èã®0.9ééïŒ é£å¡©æ°Ž83mlãžãããŸã
ãªããå ããå®å®ãªãšãã«ãžãšã³ã補é ãããå
ãšãã«ãžãšã³0.5mlãå¥ã ã®ããªãããã¬ã³è©Šéš
管ãžãããæ··åãããå ¬ç¥ã®CPDã§ååºé²æ¢ã
ãæ°ããªæ¡è¡ããããå šè¡7.5mlãšãšãã«å ããã è¡æ¶²ã¯å®æœäŸïŒèšèŒã®æ¹æ³ã§äŸè¡è ããåžåŒã
ããããªãããã¬ã³è©Šéšç®¡ã¯ã¹ããããŒã§èãã
ãåŸïŒåå転ããïŒâã§21æ¥éå·èµããã äžæ¹ã®å¯Ÿç §ããŠãŒãã¯é£å¡©æ°Žäžå¯Ÿå¿æ¿åºŠã®
Tween80äžã®è¡æ¶²ãå容ãããä»æ¹ã®å¯Ÿç §ããŠ
ãŒãã¯è¡æ¶²ã ããå容ãããããŠãžâïŒâãšãã«
ããã·ã«ãã¿ã¬ãŒãã§å¯å¡åããããªå¡©åãããŒ
ã«çãå ¥ããã 21æ¥åŸãåãµã³ãã«ã®è¡æŒ¿ãã¢ã°ããã³å«éã
枬å®ãã以äžã®ç¬¬ïŒè¡šã«ãã®çµæã瀺ãã
第ïŒå³ã¯æ¬çºæã«ãã€ãŠè£œäœããè¡æ¶²ããã°ã®
å¹³é¢å³ã§ããã ïŒïŒã¯è¡æ¶²ããã°ãïŒïŒã¯æ¡è¡ããŠãŒããïŒïŒ
ã¯å°éå£ãïŒïŒã¯ã€ã³ãµãŒãã§ããã
å¹³é¢å³ã§ããã ïŒïŒã¯è¡æ¶²ããã°ãïŒïŒã¯æ¡è¡ããŠãŒããïŒïŒ
ã¯å°éå£ãïŒïŒã¯ã€ã³ãµãŒãã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ãã®å éšã«è²¯èµãããè¡æ¶²ã®æº¶è¡ãé²æ¢ãã
ã®ã«å åãªæº¶è¡é²æ¢å€ã®æ¿åºŠã該è¡æ¶²ãžäŸçµŠãã
ããšãã§ãããè¡æ¶²å ±åæ§ã®æ» èãåŸãå¡©çŽ äžå«
ãã©ã¹ããã¯ææ補ã®è¡æ¶²è²¯èµå®¹åšã§ãã€ãŠãå
èšå®¹åšãåèšæº¶è¡é²æ¢å€ã®ãšãã«ãžãšã³ãå容ã
ãããåèšå®¹åšèªäœã®ãã©ã¹ããã¯ææããã®äž
ã«åæ£ãããè¡æ¶²ã§æº¶åºããã溶è¡é²æ¢å€ãå«æ
ãããããŸãã¯è¡æ¶²ã§æº¶åºããã溶è¡é²æ¢å€ãå«
æããè¡æ¶²å ±åæ§ã®æ» èãåŸããã©ã¹ããã¯çµæ
ç©è£œã®ã€ã³ãµãŒãéšæãå容ãããã€åèšæº¶è¡é²
æ¢å€ã¯åçåæ°ŽçŽ éã®ççŽ æ°ãïŒãªãã12ã§ãã
èèªæçåæ°ŽçŽ åºãå«ãå°ãªããšãïŒåã®ãšã¹ã
ã«çµåãæããå€å¡©åºé žèèªæãšã¹ãã«ïŒãã
ãããžãªã¯ãã«ãã¿ã¬ãŒããŸãã¯ãžãªã¯ãã«ã¢ãž
ããŒããŸãã¯ãã®æ··åç©ãåèšå®¹åšèªäœã®ææãŸ
ãã¯ã€ã³ãµãŒãéšæãžæ·»å ããå Žåãé€ããïŒã§
ããããšãç¹åŸŽãšããåèšè¡æ¶²è²¯èµå®¹åšã ïŒ åèšæº¶è¡é²æ¢å€ã®çåæ°ŽçŽ åºã¯ã¢ã«ãã«åºãŸ
ãã¯ã¢ã«ã±ãã«åºã§ãã第ïŒé ã®è¡æ¶²è²¯èµå®¹åšã ïŒ åèšæº¶è¡é²æ¢å€ã®ãšã¹ãã«çµåã¯å€å¡©åºæ§ã«
ã«ãã³é žã®çåæ°ŽçŽ éã®é£æ¥ããççŽ ååãžçµå
ããŠãã第ïŒé ãŸãã¯ç¬¬ïŒé ã®è¡æ¶²è²¯èµå®¹åšã ïŒ åèšæº¶è¡é²æ¢å€ã¯ãžã€ãœããã«ãã¿ã¬ãŒãã§
ãã第ïŒé ã®è¡æ¶²è²¯èµå®¹åšã ïŒ åèšæº¶è¡é²æ¢å€ã¯ãžã€ãœãã·ã«ãã¿ã¬ãŒãã§
ãã第ïŒé ã®è¡æ¶²è²¯èµå®¹åšã ïŒ åèšæº¶è¡é²æ¢å€ã¯ãççŽ ååæ°ïŒãªãã12ã®
èèªæçåæ°ŽçŽ åºãåããªã³ååãžçµåããå°ãª
ããšãäºã€ã®ãšã¹ãã«çµåãå«ãã§ãããªã³é žãš
ã¹ãã«ã§ãã第ïŒé ã®è¡æ¶²è²¯èµå®¹åšã ïŒ åèšãªã³é žãšã¹ãã«ã¯ããªãªã¯ãã«ãã¹ããš
ãŒãã§ãã第ïŒé ã®è¡æ¶²è²¯èµå®¹åšã ïŒ åèšå®¹åšèªäœã®ãã©ã¹ããã¯ææãŸãã¯åèš
ã€ã³ãµãŒãéšæã®ãã©ã¹ããã¯çµæç©ã¯ãå¯å¡å€
ãšããŠãäœçšããåèšæº¶è¡é²æ¢å€ã®ïŒãªãã70é
éïŒ ãå«æãã第ïŒé ã®è¡æ¶²è²¯èµå®¹åšã ïŒ åèšæº¶è¡é²æ¢å€ã®ãšãã«ãžãšã³ã¯ã該ãšãã«
ãžãšã³ã®å®å®æ§ãä¿ã€ã®ã«å åãªéã®éæ¯æ§ã®è¡
æ¶²å ±åæ§çé¢æŽ»æ§å€ãå«ãã§ãã第ïŒé ã®è¡æ¶²è²¯
èµå®¹åšã ïŒïŒ åèšçé¢æŽ»æ§å€ã¯ã³ã¬ã¹ãããŒã«ãŸãã¯ã¬
ã·ãã³ã§ãã第ïŒé ã®è¡æ¶²è²¯èµå®¹åšã ïŒïŒ åèšæº¶è¡é²æ¢å€ã®ããšã«ãžãšã³ãšå ±ã«ãè¡
液æ é€å€ããã³å®å®å€ãå容ããŠãªã第ïŒé ã®è¡
液貯èµå®¹åšã ïŒïŒ åèšæº¶è¡é²æ¢å€ã®ãšãã«ãžãšã³ã¯ãããªãª
ã¯ãã«ããªã¹ããšãŒãããžãªã¯ãã«ãã¿ã¬ãŒãã
ãžãªã¯ãã«ã¢ãžããŒããããªâïŒâãšãã«ããã·
ã«ããªã¡ãªããŒããŸãã¯ãããã®æ··åç©ãå«ãã§
ãã第ïŒé ãªãã第ïŒïŒé ã®ããããã®è¡æ¶²è²¯èµ
容åšã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/105,468 US4326025A (en) | 1979-12-19 | 1979-12-19 | Anti-hemolytic agent emulsions and the use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5691758A JPS5691758A (en) | 1981-07-24 |
| JPH0131904B2 true JPH0131904B2 (ja) | 1989-06-28 |
Family
ID=22306022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1195380A Granted JPS5691758A (en) | 1979-12-19 | 1980-02-01 | Hemolysis preventing emulsion and use thereof |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4326025A (ja) |
| JP (1) | JPS5691758A (ja) |
| BE (1) | BE881623R (ja) |
| CA (1) | CA1140472A (ja) |
| ZA (1) | ZA802069B (ja) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0051414B1 (en) * | 1980-10-31 | 1985-02-20 | Baxter Travenol Laboratories, Inc. | Blood storage container and material |
| US5382526A (en) * | 1980-10-31 | 1995-01-17 | Baxter International Inc. | Blood storage container and material |
| EP0054221B1 (en) * | 1980-12-15 | 1986-04-09 | Miles Inc. | Multiple blood bag system made of plastic substantially free of blood extractible plasticizers |
| US4386069A (en) * | 1981-12-02 | 1983-05-31 | Baxter Travenol Laboratories, Inc. | Additive solution and method for preserving normal red cell morphology in whole blood during storage |
| US4432750A (en) * | 1981-12-02 | 1984-02-21 | Baxter Travenol Laboratories, Inc. | Additive sterol solution and method for preserving normal red cell morphology in whole blood during storage |
| US4731260A (en) * | 1984-12-18 | 1988-03-15 | American Hospital Supply Corporation | Hydrophobic filter material and method |
| US4850993A (en) * | 1986-12-22 | 1989-07-25 | Miles Laboratories, Inc. | Blood bag system incorporating quinolone carboxylic, acid derivatives |
| AU610120B2 (en) * | 1987-01-13 | 1991-05-16 | Kao Corporation | Hemolysis depressent and blood preserving composition |
| US5248531A (en) * | 1987-01-13 | 1993-09-28 | Terumo Kabushiki Kaisha | Hemolysis depressant and plasticizer |
| US5026347A (en) * | 1988-11-14 | 1991-06-25 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US5167657A (en) * | 1988-11-14 | 1992-12-01 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US5100401A (en) * | 1988-11-14 | 1992-03-31 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US5407424A (en) * | 1993-02-24 | 1995-04-18 | Scimed Life Systems, Inc. | Angioplasty perfusion pump |
| FR2820951B1 (fr) * | 2001-02-20 | 2004-06-11 | Bernard Sa | Dispositif et procede pour prelever et collecter le sang d'un animal |
| JP2007009611A (ja) * | 2005-07-04 | 2007-01-18 | åç· â²åâŒå· | ãã¯ãŒã·ã§ãã«çšãã±ãã |
| US9144958B2 (en) * | 2009-10-28 | 2015-09-29 | Fenwal, Inc. | Sheets for use with medical containers |
| US10398625B2 (en) | 2013-03-13 | 2019-09-03 | Fenwal, Inc. | Medical containers with terephthalate plasticizer for storing red blood cell products |
| KR102554521B1 (ko) | 2014-02-20 | 2023-07-11 | íë ì ëì°ì€ ì¹Žë¹ ëìŽì¹ëíž ê²ì ë² í | ì í구 ì í, íì¥ ë° íìíì 볎êŽì ìí ë¹-ïœïœ ïœïœ ê°ìì 륌 ê°ë ìë£ì© 컚í ìŽë ë° ìì€í 구ì±ìì |
-
1979
- 1979-12-19 US US06/105,468 patent/US4326025A/en not_active Expired - Lifetime
-
1980
- 1980-02-01 JP JP1195380A patent/JPS5691758A/ja active Granted
- 1980-02-06 CA CA000345163A patent/CA1140472A/en not_active Expired
- 1980-02-08 BE BE0/199323A patent/BE881623R/fr not_active IP Right Cessation
- 1980-04-08 ZA ZA00802069A patent/ZA802069B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US4326025A (en) | 1982-04-20 |
| JPS5691758A (en) | 1981-07-24 |
| BE881623R (fr) | 1980-08-08 |
| CA1140472A (en) | 1983-02-01 |
| ZA802069B (en) | 1981-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0131904B2 (ja) | ||
| US4286597A (en) | Blood compatible polymers and medical devices made therefrom containing dioctyladipate plasticizer | |
| US4222379A (en) | Multiple blood bag having plasticizer-free portions and a high blood component survival rate | |
| US4670013A (en) | Container for blood and blood components | |
| EP0120873B1 (en) | A blood component storage container and method utilizing a polyvinyl chloride plastic formulation free or essentially free of leachable materials | |
| US4301800A (en) | Blood bags having an insert member | |
| EP0537863B1 (en) | Use of a triglyceride compound as a hemolysis depressant | |
| US5382526A (en) | Blood storage container and material | |
| GB2065446A (en) | Storing blood in an antihemolytic environment | |
| US4507387A (en) | Method of storing red blood cells which minimizes both red blood cell hemolysis and exposure to blood extractable plasticizers | |
| US4375509A (en) | Anti-hemolytic agent emulsions | |
| US5248531A (en) | Hemolysis depressant and plasticizer | |
| EP0334956A1 (en) | Hemolysis inhibitor and medical resin composition, medical implement, and blood-preserving fluid containing the same | |
| CA1285094C (en) | Pvc containers for blood and blood components | |
| EP0331729A1 (en) | Medical implements | |
| WO1984001292A1 (en) | Method and container for storing platelets | |
| JPH038778B2 (ja) | ||
| CA1154684A (en) | Hemocompatible addition solutions and use thereof | |
| CA1158562A (en) | Hemocompatible addition solutions and use thereof | |
| CA1306698C (en) | Hemolysis depressant, and medical resin composition, medical implement and blood preserving liquid using the hemolysis depressant | |
| EP4285721A1 (en) | System for the extended storage of red blood cells | |
| CA1251108A (en) | Multiple blood bag having plasticizer-free portions and a high blood component survival rate | |
| JPH0242507B2 (ja) | ||
| JPS62281946A (ja) | è¡æ¶²ããã°ã»ãã | |
| AU1947083A (en) | Method and container for storing platelets |